Oria Bioscience is a pure biotechnology company that produces intact organelles for therapeutic opportunities.
Oria Bioscience has raised $3.1M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
Oria Bioscience's investors include Newfund, Galion.exe, Cenitz, Calyseed.
Oria Bioscience is headquartered in Paris, France.
Oria Bioscience is a pure biotechnology company that produces intact organelles for therapeutic opportunities.
Oria Bioscience is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oria Bioscience — Funding & Investors." VCBacked, June 19, 2025, https://www.vcbacked.co/company/oria-bioscience. Accessed September 30, 2026.
VCBacked. (2025). Oria Bioscience — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/oria-bioscience
{{cite web |title=Oria Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/oria-bioscience |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated